Discover Luxurious Escapes: Hyatt’s Spa Cave, Hilton’s Hot Springs Resort, Andaz in the Alps, and MoreMarch 2, 2026
Promising Survival Trends in NSCLC: HARMONI-2 Study Highlights Akeso’s Approach Against Pembrolizumab Business April 26, 2025 An interim analysis of the HARMONI-2 trial indicates that the investigational drug Ivonescimab shows a 22% reduction in the risk…